Aldehyde dehydrogenases (ALDH4A1 and ALDH6A1) overexpression has been shown to be associated with poorer overall patient survival, particularly in breast, head and neck, cervical and ovarian cancers (Xia et al., 2023). This evidence concerns the gene ALDH6A1 and ovarian carcinoma.